Para-Methoxymethamphetamine

para-Methoxymethamphetamine (PMMA), is a stimulant drug related to para-methoxyamphetamine (PMA).



PMMA reputedly produces similar effects to PMA, but is apparently slightly more similar to MDMA in effects and has slightly less tendency to produce severe hyperthermia, at least at low doses. At higher doses however the side effects and danger of death are just as severe as those of PMA itself.

PMMA is a lesser-known psychedelic drug. It is the 4-methoxy analog of methamphetamine. PMMA was probably first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 100 mg, and the duration unknown. Shulgin reported that methyl-MA produces an increase in blood pressure and in heart rate, but causes no psychoactive effects, however user reports following the subsequent appearance of this drug on the illicit market as an analogue of "Ecstasy" (MDMA) suggest that PMMA does produce some empathogenic effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of PMMA, and given the known toxicity of the related compound PMA it is likely to have considerable potential to cause harmful side effects or overdose which can be fatal.

Reported deaths
31 January 2011 the Norwegian Broadcasting Corporation reported that Norway had seen a staggering 12 deaths related to this drug in just 6 months.

31 March 2011 Dutch media reported that the Netherlands (Limburg province) had seen 4 deaths related to this drug since November 2010.

30 April 2011 Icelandic media reported that Iceland had seen 1 death of a young woman that may have been related to this drug.